Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Chemistry & Biology|March 29, 2011
JAK3 specific kinase inhibitors: when specificity is not enoughLuk Cox, Jan CoolsRNA (New York, N.Y.)|April 28, 2012
Development of a siRNA and shRNA screening system based on a kinase fusion proteinSofie Pieraets, Luk Cox, Olga Gielen, et al.Molecular Oncology|March 13, 2014
The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842VLaura A Noël, Florence A Arts, Carmen P Montano-Almendras, et al.Blood Cancer Discovery|October 18, 2021
Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic LeukemiaHeidi Segers, Jan CoolsPharmaceuticals (Basel, Switzerland)|June 2, 2021
Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid MalignanciesInge Lodewijckx, Jan CoolsExpert Review of Anticancer Therapy|September 19, 2009
Recent breakthroughs in the understanding and management of chronic eosinophilic leukemiaEls Lierman, Jan CoolsNature Genetics|October 29, 2015
The genomic landscape of adult T cell leukemia/lymphomaCarmen Vicente, Jan CoolsJournal of Hematology & Oncology|July 26, 2015
JAK kinase inhibitors for the treatment of acute lymphoblastic leukemiaSandrine Degryse, Jan CoolsImmunology and Allergy Clinics of North America|September 18, 2007
Novel approaches to therapy of hypereosinophilic syndromesHans-Uwe Simon, Jan CoolsPageof 15